Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy
TIRIBELLI, Mario
•
MEDEOT, Marta
•
FANIN, Renato
altro
Bonifacio, Massimiliano
2015